These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog. Watson CJ; Cobbold SP; Davies HS; Rebello PR; Waldmann H; Calne RY; Metcalfe SM Br J Surg; 1993 Nov; 80(11):1389-92. PubMed ID: 8252344 [TBL] [Abstract][Full Text] [Related]
8. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies. Moffatt SD; Metcalfe SM Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271 [No Abstract] [Full Text] [Related]
9. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies. Moffatt SD; McAlister V; Calne RY; Metcalfe SM Transplant Proc; 1999 Nov; 31(7):2754. PubMed ID: 10578277 [No Abstract] [Full Text] [Related]
11. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats. Kuttler B; Rösing K; Hahn HJ Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572 [No Abstract] [Full Text] [Related]
12. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches. Duguid IG; Koulmanda M; Mandel TE Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499 [No Abstract] [Full Text] [Related]
13. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
14. Depletion of IL-4 does not prevent tolerance induction in an allogeneic rat kidney transplantation model. Ritter T; Seifert M; Risch K; Fretz A; Tanzmann H; Brock J; Volk HD; Lehmann M Transplant Proc; 1999; 31(1-2):887-8. PubMed ID: 10083389 [No Abstract] [Full Text] [Related]
16. CD4+ lymphocytes play a dominant role in murine xenograft rejection. Pierson RN; Winn HJ; Russell PS; Auchincloss H Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056 [No Abstract] [Full Text] [Related]
17. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Cobbold SP; Qin S; Leong LY; Martin G; Waldmann H Immunol Rev; 1992 Oct; 129():165-201. PubMed ID: 1464419 [No Abstract] [Full Text] [Related]
18. Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis. Pelegrà C; Morante MP; Castellote C; Franch A; Castell M Clin Exp Immunol; 1996 Feb; 103(2):273-8. PubMed ID: 8565311 [TBL] [Abstract][Full Text] [Related]
19. Tolerance induction with peripheral blood lymphocyte depletion using monoclonal antibodies: tip of the iceberg? Soin AS; Metcalfe S; Friend PJ Transplant Proc; 1998 Sep; 30(6):2572. PubMed ID: 9745493 [No Abstract] [Full Text] [Related]
20. Mechanism of corneal endothelial destruction in rejecting rat corneal allografts and xenografts: a role for CD4+ cells. Takano T; Williams KA Transplant Proc; 1995 Feb; 27(1):260-1. PubMed ID: 7878994 [No Abstract] [Full Text] [Related] [Next] [New Search]